Kura Oncology (KURA) Retained Earnings (2010 - 2026)
Kura Oncology (KURA) reported Retained Earnings of -$1.2 billion for Q1 2026, down 128171.97% year-over-year from N/an in Q1 2025, and down 6.25% on a QoQ basis from -$1.2 billion in Q4 2025.
Kura Oncology (KURA) has 17 years of Retained Earnings data on file, last reported at -$1.2 billion in Q1 2026.
- Quarterly Retained Earnings fell 128171.97% year-over-year to -$1.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.2 billion (down 128171.97% YoY) and the FY2025 annual result came in at -$1.2 billion, down 31.12% from the prior year.
- Retained Earnings retreated to -$1.2 billion in Q1 2026 per KURA's latest filing, from -$1.2 billion in the prior quarter.
- Across five years, Retained Earnings topped out at $974000.0 in Q1 2025 and bottomed at -$1.2 billion in Q1 2026.
- The 5-year median for Retained Earnings is -$9.4 million (2022), against an average of -$454.1 million.
- Peak annual rise in Retained Earnings reached 100.13% in 2025, while the deepest fall reached 219980.56% in 2025.
- Tracing KURA's Retained Earnings over 5 years: stood at -$8.0 million in 2022, then surged by 84.18% to -$1.3 million in 2023, then plunged by 70350.2% to -$895.4 million in 2024, then sank by 31.12% to -$1.2 billion in 2025, then retreated by 6.25% to -$1.2 billion in 2026.
- Per Business Quant, the three latest KURA Retained Earnings figures stand at -$1.2 billion (Q1 2026), -$1.2 billion (Q4 2025), and -$1.1 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 130.89 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 36.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Kura Oncology | 801.92 Mn | 801.92 Mn | 18.00 Mn | -1.25 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.25 Bn |
| Dec 31, 2025 | -1.17 Bn |
| Sep 30, 2025 | -1.09 Bn |
| Jun 30, 2025 | -1.02 Bn |
| Mar 31, 2025 | 974,000.00 |
| Dec 31, 2024 | -895.42 Mn |
| Sep 30, 2024 | -876.21 Mn |
| Jun 30, 2024 | -463,000.00 |
| Mar 31, 2024 | -770.96 Mn |
| Dec 31, 2023 | -1.27 Mn |
| Sep 30, 2023 | -3.54 Mn |
| Jun 30, 2023 | -5.22 Mn |
| Mar 31, 2023 | -602.88 Mn |
| Dec 31, 2022 | -8.03 Mn |
| Sep 30, 2022 | -9.42 Mn |
| Jun 30, 2022 | -7.82 Mn |
| Mar 31, 2022 | -6.65 Mn |
| Dec 31, 2021 | -1.79 Mn |
| Sep 30, 2021 | -400.23 Mn |
| Jun 30, 2021 | -393,000.00 |
| Mar 31, 2021 | -333.20 Mn |
| Dec 31, 2020 | 46,000.00 |
| Sep 30, 2020 | -276.34 Mn |
| Jun 30, 2020 | 557,000.00 |
| Mar 31, 2020 | -232.09 Mn |
| Dec 31, 2019 | -212.88 Mn |
| Sep 30, 2019 | -195.01 Mn |
| Jun 30, 2019 | -178.62 Mn |
| Mar 31, 2019 | 18,000.00 |
| Dec 31, 2018 | -149.74 Mn |
| Sep 30, 2018 | -123,000.00 |
| Jun 30, 2018 | -118.63 Mn |
| Mar 31, 2018 | -103.89 Mn |
| Dec 31, 2017 | -49,000.00 |
| Sep 30, 2017 | -78.54 Mn |
| Jun 30, 2017 | -69.21 Mn |
| Mar 31, 2017 | -19,000.00 |
| Dec 31, 2016 | -53.86 Mn |
| Sep 30, 2016 | -46.51 Mn |
| Jun 30, 2016 | -39.58 Mn |
| Mar 31, 2016 | 11,000.00 |
| Dec 31, 2015 | -26.30 Mn |
| Sep 30, 2015 | 1,000.00 |
| Jun 30, 2015 | -14,000.00 |
| Mar 31, 2015 | -8.15 Mn |
| Dec 31, 2014 | -3.67 Mn |
| Sep 30, 2014 | 193,038.00 |
| Jun 30, 2014 | 186,610.00 |
| Mar 31, 2014 | 179,723.00 |
| Dec 31, 2013 | 173,957.00 |
| Sep 30, 2013 | 164,207.00 |
| Jun 30, 2013 | 158,068.00 |
| Mar 31, 2013 | 151,319.00 |
| Dec 31, 2012 | 145,346.00 |
| Sep 30, 2012 | 135,684.00 |
| Jun 30, 2012 | 129,671.00 |
| Mar 31, 2012 | 123,403.00 |
| Dec 31, 2011 | 118,031.00 |
| Sep 30, 2011 | 109,147.00 |
| Jun 30, 2011 | 102,880.00 |
| Mar 31, 2011 | 118,031.00 |
| Dec 31, 2010 | 90,991.00 |